Trellis Advisors, LLC Abb Vie Inc. Transaction History

Trellis Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $2,671 - $3,093	20 Added 0.71%	2,852 $425,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $3,047 - $3,792	-23 Reduced 0.81%	2,832 $381,000
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $3,470 - $3,996	24 Added 0.85%	2,855 $455,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $13,831 - $16,587	-100 Reduced 3.41%	2,831 $457,000
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $8,186 - $9,389	61 Added 2.13%	2,931 $394,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $11,147 - $14,171	81 Added 2.9%	2,870 $439,000
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $2,639 - $3,275	-20 Reduced 0.71%	2,789 $452,000
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $3,867 - $4,893	-36 Reduced 1.27%	2,809 $380,000
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $2,660 - $3,019	25 Added 0.89%	2,845 $307,000
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $631 - $703	-6 Reduced 0.21%	2,820 $318,000
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $42,659 - $46,962	417 Added 17.31%	2,826 $306,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $193,900 - $261,786	2,409 New	2,409 $258,000
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $192,610 - $226,060	-2,242 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $164,495 - $220,119	2,242 New	2,242 $220,000
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $198,833 - $266,256	-2,161 Closed	0 $0
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $193,539 - $212,231	2,161	2,161 $209,000

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Trellis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellis Advisors, LLC with notifications on news.